Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Plant extracts >  Hederacoside C

Hederacoside C

Basic information Safety Supplier Related

Hederacoside C Basic information

Product Name:
Hederacoside C
Synonyms:
  • KIZUTA SAPONIN K(12
  • HEDERACOSIDE C WITH HPLC
  • Olean-12-en-28-oic acid, 3-[[2-O-(6-deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl]oxy]-23-hydroxy-, O-6-deoxy-alpha-l-mannopyranosyl-(1->4)-O-beta-d-glucopyranosyl-(1->6)-beta-d-glucopyranosyl ester, (3beta,4alpha)-
  • kalopanax saponin B
  • HEDERACOSIDE C
  • (3beta,4alpha)-3-[[2-O-(6-Deoxy-alpha-l-mannopyranosyl)-alpha-l-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-28-oic acid O-6-deoxy-alpha-l-mannopyranosyl-(1->4)-O-beta-d-glucopyranosyl-(1->6)-beta-d-glucopyranosyl ester
  • Hederacoside c, froM Hedera nepalensis
  • 4)-O-b-D-glucopyranosyl-(1®
CAS:
14216-03-6
MF:
C59H96O26
MW:
1221.38
EINECS:
238-072-2
Product Categories:
  • chemical reagent
  • pharmaceutical intermediate
  • phytochemical
  • reference standards from Chinese medicinal herbs (TCM).
  • standardized herbal extract
  • AliphaticAnalytical Standards
  • Herbal DrugsChromatography
  • Alcohols
  • Chemical Class
  • EstersAlphabetic
  • H
  • HA -HTChemical Class
  • Heterocyclics
  • Life Sciences Standards
  • Natural Compounds
  • Natural CompoundsChemical Class
  • Natural Terpene StandardsChemical Class
  • Oxygen containingChemical Class
  • Polyhydroxy compoundsMore...Close...
Mol File:
14216-03-6.mol
More
Less

Hederacoside C Chemical Properties

Melting point:
222 °C (dec.)(lit.)
Density 
1.48±0.1 g/cm3(Predicted)
storage temp. 
Inert atmosphere,2-8°C
solubility 
DMSO (Slightly), Methanol (Slightly, Sonicated), Pyridine (Sparingly)
pka
12.50±0.70(Predicted)
form 
Solid
color 
White to Pale Beige
BRN 
4229541
Stability:
Hygroscopic
Major Application
food and beverages
InChIKey
RYHDIBJJJRNDSX-MCGLQMIESA-N
LogP
4.520 (est)
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
Safety Statements 
22-24/25
RIDADR 
UN 2811 6.1/PG 3
WGK Germany 
3
10-23
HS Code 
29389090
Storage Class
11 - Combustible Solids
Hazard Classifications
Acute Tox. 4 Oral

MSDS

More
Less

Hederacoside C Usage And Synthesis

Chemical Properties

White powder

Uses

Hederacoside C is a Hedera helix leaf which has been used in botanical drug formulations to treat acute respiratory infection and bronchitis. Anti-myocardial.

Uses

solubilizer, bio-availability enhancer in oral suspensions, capsules

Definition

ChEBI: A triterpenoid saponin with hederagenin as the aglycone part. It has been isolated from the stem bark of Kalopanax pictus.

Synthesis

Take dry manipulation ivy stems and leaves 500g, crushed, with 30% ethanol 4000mL, 2000mL at 80 ?? successively heated reflux for two times, reflux time were 3 hours, 2 hours. Combine the two extracts, decompression recovery of solvent, get ivy crude extract. The crude extract of ivy was dissolved in 150 mL of water in an ultrasonic generator, and the aqueous solution was extracted with equal volumes of ether, ethyl acetate and n-butanol for three times, respectively. The three n-butanol extracts were combined, concentrated under reduced pressure to near dryness and dissolved in 80 mL of 95% ethanol. Gradually add ethyl acetate to the 95% ethanol solution under stirring until no more precipitate was produced, and then collect the precipitate by filtration after 2 hours of standing. The precipitate was dissolved with a small amount of methanol and eluted by column chromatography using silica gel as stationary phase and a mixture of chloroform:methanol equal to 65:35 as mobile phase. The eluent was collected, and the collected eluent containing ivyoside C was concentrated and freeze-dried to obtain ivyoside C1.0759 g, and the content of ivyoside C was 98.2% as detected by high performance liquid chromatography.

in vivo

Hederacoside C (0.625, 1.25, 2.5 mg/kg, intraperitoneally injected for 7 consecutive days) can alleviate TNBS-induced enteritis[1].
Hederacoside C (5, 10, 50 mg/kg, intraperitoneally injected for 3 consecutive times for 8 h) can attenuate the breast lesions caused by Staphylococcus aureus[2].

Animal Model:TNBS-induced colitis in rat[1]
Dosage:0.625, 1.25, 2.5 mg/kg
Administration:i.p. for 7 days
Result:Decreased the levels of inflammatory cytokines, including TNF-α, IL-6, IL-1β, CXCL-1, CXCL-2, and CXCL-5.
Reduced cell apoptosis in TNBS-induced colitis.
Reduced Bax/Bcl-2 ratio, cleaved caspase 3, and p53 protein levels in a dose-dependent manner.

Hederacoside CSupplier

Shanghai YuanYe Biotechnology Co., Ltd. Gold
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Chengdu Biopurify Phytochemicals Ltd. Gold
Tel
+86-028-82633397 18982077548
Email
cwb1@biopurify.cn
Chengdu Nakeli Biotechnology Co., Ltd. Gold
Tel
028-61983833 19138982515
Email
3265827856@qq.com
J & K SCIENTIFIC LTD.
Tel
18210857532; 18210857532
Email
jkinfo@jkchemical.com
Chembest Research Laboratories Limited
Tel
+86-21-20908456
Email
sales@BioChemBest.com